51073-69-9

Basic information

• Product Name: 2-AMino-5-iodobenzophenone
• Synonyms: 2-AMino-5-iodobenzophenone;(2-Amino-5-iodophenyl)(phenyl)methanone
• CAS NO: 51073-69-9
• Molecular Formula: C₁₃H₁₀INO
• Molecular Weight: 323.12907
• Mol File: 51073-69-9.mol

Chemical Properties

• Melting Point: 223-225℃
• Boiling Point: 458.2±40.0 °C(Predicted)
• Appearance: /
• Density: 1.683
• PKA: -0.10±0.10(Predicted)
• CAS DataBase Reference: 2-AMino-5-iodobenzophenone(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMino-5-iodobenzophenone(51073-69-9)
• EPA Substance Registry System: 2-AMino-5-iodobenzophenone(51073-69-9)

Safety Data

• Hazardous Substances Data: 51073-69-9(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Journal of Medicinal Chemistry, 32, p. 1157, 1989 DOI: 10.1021/jm00126a003

Upstream product

• 100675-76-1 5-iodo-3-phenyl-2.1-benzoisoxazole 
• 591-51-5 phenyllithium 
• 5326-47-6 2-amino-5-iodobenzoic acid 
• 636-98-6 p-nitrobenzene iodide 
• 140-29-4 phenylacetonitrile 
• 2835-77-0 (2-aminophenyl)(phenyl)methanone 
• 13209-38-6 (2-aminophenyl)(phenyl)methanol 
• 552-89-6 2-nitro-benzaldehyde 
• 529-23-7 o-aminobenzaldehyde 

Downstream Products

• 97423-32-0 N-(2-Benzoyl-4-iodo-phenyl)-2-bromo-acetamide 
• 60114-64-9 7-iodo-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one 
• 97423-33-1 1,3-dihydro-7-iodo-5-phenyl-2H-1,4-benzodiazepine-2-thione 
• 97423-34-2 8-Iodo-6-phenyl-1-(phenylmethyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine 
• 1082051-53-3 C₂₁H₂₃IN₂O₄ 
• 1300090-39-4 phenylmethyl (1-amino-2-{[4-iodo-2-(phenylcarbonyl)phenyl]amino}-2-oxoethyl)carbamate 
• 1300090-04-3 benzyl N-(7-iodo-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)carbamate 
• 1300089-84-2 phenylmethyl (7-iodo-5-phenyl-2-thioxo-2,3-dihydro-1H-1,4-benzo diazepin-3-yl)carbamate 
• 1300089-87-5 3-amino-7-iodo-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 
• 1300089-86-4 1,1-dimethylethyl (7-iodo-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzo diazepin-3-yl)carbamate 
• 1332671-52-9 C₂₂H₂₆IN₃O 
• 1332661-03-6 (RS)-6-iodo-2-methyl-4-phenyl-3-(2-(piperidin-1-yl)ethyl)-3,4-dihydroquinazoline 
• 1309784-43-7 C₂₁H₁₃FIN 
• 1309784-45-9 C₂₇H₁₈FN 

Relevant articles and documents

NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF

A class of compounds that bind to fatty acid binding protein (FABP4) and modulate adipocyte metabolism to drive enhanced glucose utilization, as well as pharmaceutical compositions comprising the class of compounds, in combination with a pharmaceutically acceptable diluent or carrier, and optionally, further in combination with a therapeutically active agent, and the use of these compounds in medicine and for the preparation of a medicament in the treatment of disorders acting on the FABP4.

Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin

High-throughput screening has shown that Retro-1 inhibits ricin and Shiga toxins by diminishing their intracellular trafficking via the retrograde route, from early endosomes to the Golgi apparatus. To improve the activity of Retro-1, a structure-activity relationship (SAR) study was undertaken and yielded an analogue with a roughly 70-fold better half-maximal effective concentration (EC50) against Shiga toxin cytotoxicity measured in a cell protein synthesis assay.

Deoxygenative Arylation of Carboxylic Acids by Aryl Migration

An unprecedented deoxygenative arylation of aromatic carboxylic acids has been achieved, allowing the construction of an enhanced library of unsymmetrical diaryl ketones. The synergistic photoredox catalysis and phosphoranyl radical chemistry allows for precise cleavage of a stronger C?O bond and formation of a weaker C?C bond by 1,5-aryl migration under mild reaction conditions. This new protocol is independent of substrate redox-potential, electronic, and substituent effects. It affords a general and promising access to 60 examples of synthetically versatile o-amino and o-hydroxy diaryl ketones under redox-neutral conditions. Furthermore, it also brings one concise route to the total synthesis of quinolone alkaloid, (±)-yaequinolone A2, and a viridicatin derivative in satisfying yields.

Thermolysis and radiofluorination of diaryliodonium salts derived from anilines

Aniline-derived diaryliodonium salts were synthesized and functionalized in good to excellent yields by judicious utilization of electron-withdrawing protecting groups. This simple approach opens another route to radiolabeling amino arenes in relatively complex molecules, such as flutemetamol.

Synthesis of 3-Substituted 2,1-Benzisoxazoles by the Oxidative Cyclization of 2-Aminoacylbenzenes with Oxone

An efficient approach to the synthesis of 2,1-benzisoxazoles through direct construction of the N-O bond by the chemoselective oxidation of 2-aminoacylbenzenes with Oxone is described. This alternative methodology is characterized by its simple and transition-metal-free conditions and good functional group compatibility utilizing Oxone as a green oxidant instead of hypervalent iodine compounds. Moreover, this new procedure simplifies the number of steps compared to the previously reported procedure by circumventing the use of 2-azido-substituted aryl ketones.

IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND USE THEREFOR

It is an object of the present invention to provide a red phosphorescent compound having a high emission quantum yield, which is used for producing organic EL elements. The red phosphorescent compound of the present invention is an iridium complex compound represented by the following formula (1). In the formula (1), L1 is selected from the following formulas (2) and (3).

Condensed Azepine Derivatives As Bromodomain Inhibitors

Benzodiazepine compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.

Metal-free intramolecular oxidative decarboxylative amination of primary α-amino acids with product selectivity

A novel metal-free intramolecular oxidative decarboxylative coupling of primary α-amino acids with 2-aminobenzoketones under mild and neutral conditions was developed. Different quinazolines can be selectively obtained by various oxidants.

Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: Discovery, synthesis, and characterization of their binding mode by protein crystallography

Trypanothione reductase (TryR) is a genetically validated drug target in the parasite Trypanosoma brucei, the causative agent of human African trypanosomiasis. Here we report the discovery, synthesis, and development of a novel series of TryR inhibitors based on a 3,4-dihydroquinazoline scaffold. In addition, a high resolution crystal structure of TryR, alone and in complex with substrates and inhibitors from this series, is presented. This represents the first report of a high resolution complex between a noncovalent ligand and this enzyme. Structural studies revealed that upon ligand binding the enzyme undergoes a conformational change to create a new subpocket which is occupied by an aryl group on the ligand. Therefore, the inhibitor, in effect, creates its own small binding pocket within the otherwise large, solvent exposed active site. The TryR-ligand structure was subsequently used to guide the synthesis of inhibitors, including analogues that challenged the induced subpocket. This resulted in the development of inhibitors with improved potency against both TryR and T. brucei parasites in a whole cell assay.

CONDENSED AZEPINE DERIVATIVES AS BROMODOMAIN INHIBITORS

Benzodiazepine compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.